PMGC Holdings (ELAB) Operating Expenses (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Operating Expenses came in at $4.2 million in Q2 2026, up 18.22% quarter-over-quarter from $3.6 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Operating Expenses (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Operating Expenses across 5 years of filings, most recently posting $4.2 million for Q2 2026.
- In Q2 2026, Operating Expenses changed N/A year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $12.6 million (changed N/A YoY), while the FY2025 annual figure was $7.1 million, changed N/A from the prior year.
- Operating Expenses came in at $4.2 million for Q2 2026 at PMGC Holdings, up from $3.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $709.5 million in Q3 2022 to a low of -$1.5 billion in Q4 2022.
- Average Operating Expenses over 5 years is -$56.6 million, with a median of $1.8 million recorded in 2024.
- Year-over-year, Operating Expenses sank 99.84% in 2023 and jumped 125.36% in 2024.
- Over 5 years, Operating Expenses stood at -$1.5 billion in 2022, then jumped by 100.11% to $1.5 million in 2023, then dropped by 14.84% to $1.3 million in 2024, then soared by 96.01% to $2.6 million in 2025, then jumped by 63.6% to $4.2 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $4.2 million in Q2 2026, $3.6 million in Q1 2026, and $2.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.09 Bn | 192.10 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 179.75 Bn | 176.57 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 131.11 Bn | 123.26 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 60.45 Bn | 55.27 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 53.60 Bn | 48.46 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.36 Bn | 30.06 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.72 Bn | 30.44 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 29.09 Bn | 29.09 Bn | 1.16 Mn | 367.83 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 4.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.21 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 2.58 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 944,776.00 |
| Dec 31, 2022 | -1.47 Bn |
| Sep 30, 2022 | 709.53 Mn |